We are live on ! Find out more
WTA

Washington Trust Advisors Portfolio holdings

AUM $1.35B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+87.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
+$72.5M
Cap. Flow
-$2.66M
Cap. Flow %
-0.23%
Top 10 Hldgs %
38.44%
Holding
689
New
30
Increased
137
Reduced
152
Closed
27

Top Buys

Rank Stock Value
1
AMTM
Amentum Holdings
AMTM
+$3.65M
2
EW icon
Edwards Lifesciences
EW
+$1.71M
3
ARE icon
Alexandria Real Estate Equities
ARE
+$1.47M
4
ETN icon
Eaton
ETN
+$1.3M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$1.22M

Top Sells

Rank Stock Value
1
J icon
Jacobs Solutions
J
+$4.17M
2
VUG icon
Vanguard Growth ETF
VUG
+$1.23M
3
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
+$1.22M
4
UPS icon
United Parcel Service
UPS
+$1.03M
5
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$827K

Sector Composition

Rank Sector Weight
1 Technology 19.09%
2 Healthcare 15.35%
3 Industrials 12.65%
4 Communication Services 12.34%
5 Consumer Discretionary 11.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEO icon
626
American Eagle Outfitters
AEO
$2.94B
$2.51K ﹤0.01%
112
– –
DKNG icon
627
DraftKings
DKNG
$12.2B
$2.5K ﹤0.01%
+64
New +$2.31K
FANG icon
628
Diamondback Energy
FANG
$56B
$2.47K ﹤0.01%
14
– –
MRNA icon
629
Moderna
MRNA
$21.6B
$2.34K ﹤0.01%
35
– –
LAW icon
630
CS Disco
LAW
$271M
$2.33K ﹤0.01%
397
– –
KURA icon
631
Kura Oncology
KURA
$793M
$2.25K ﹤0.01%
115
– –
FLNA
632
Filana Therapeutics
FLNA
$42M
$2.21K ﹤0.01%
75
– –
CGEM icon
633
Cullinan Oncology
CGEM
$1.06B
$2.13K ﹤0.01%
127
– –
EYPT icon
634
EyePoint Inc
EYPT
$999M
$2.11K ﹤0.01%
264
– –
NYC
635
American Strategic Investment Co
NYC
$30.4M
$2.07K ﹤0.01%
224
– –
SNDX icon
636
Syndax Pharmaceuticals
SNDX
$1.7B
$2.06K ﹤0.01%
107
– –
NARI
637
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.9K ﹤0.01%
46
– –
RVNC
638
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.89K ﹤0.01%
364
– –
CGON icon
639
CG Oncology
CGON
$6.1B
$1.85K ﹤0.01%
49
– –
XPEV icon
640
XPeng
XPEV
$12.5B
$1.83K ﹤0.01%
150
– –
GPCR icon
641
Structure Therapeutics
GPCR
$3.37B
$1.8K ﹤0.01%
41
– –
BSY icon
642
Bentley Systems
BSY
$11.2B
$1.71K ﹤0.01%
34
– –
THC icon
643
Tenet Healthcare
THC
$22.2B
$1.68K ﹤0.01%
+10
New +$1.51K
RPAY icon
644
Repay Holdings
RPAY
$335M
$1.67K ﹤0.01%
205
– –
BTAI icon
645
BioXcel Therapeutics
BTAI
$24.8M
$1.57K ﹤0.01%
161
– –
TLK icon
646
Telkom Indonesia
TLK
$14.2B
$1.56K ﹤0.01%
79
-129
-62% -$2.48K
TWST icon
647
Twist Bioscience
TWST
$5.32B
$1.45K ﹤0.01%
32
– –
ABEV icon
648
Ambev
ABEV
$47.9B
$1.4K ﹤0.01%
572
-1,152
-67% -$2.58K
LUNG icon
649
Pulmonx
LUNG
$52.8M
$1.39K ﹤0.01%
167
– –
FIGS icon
650
FIGS
FIGS
$1.76B
$1.33K ﹤0.01%
195
– –
24 25
26
27 28

Similar funds

VHAM
Van Hulzen Asset Management El Dorado Hills, California $1.35B AUM 22.73% 1-Year Est. Return
ME
McIlrath & Eck Arlington, Washington $1.35B AUM 15.78% 1-Year Est. Return
HAM
HoldCo Asset Management Fort Lauderdale, Florida $1.34B AUM 28.06% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.35B AUM 27.53% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
FFW
Fusion Family Wealth Woodbury, New York $1.34B AUM 18.88% 1-Year Est. Return
WTB
Washington Trust Bank Spokane, Washington $1.36B AUM 21.14% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

Washington Trust Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Washington Trust Advisors held 689 positions worth $1.16B, up 6.7% from $1.09B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Washington Trust Advisors's Q3 2024 filing shows 30 new, 137 increased, 152 reduced and 27 closed positions. Its largest new stake was Amentum Holdings: 128,198 shares worth $4.13M. The largest sale was Jacobs Solutions, an estimated $4.17M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Washington Trust Advisors's largest Q3 2024 buy was Amentum Holdings: 128,198 shares worth $4.13M.
  • Washington Trust Advisors added most to Edwards Lifesciences in Q3 2024, an estimated $1.71M increase.
  • Washington Trust Advisors's biggest Q3 2024 reduction was Jacobs Solutions, cutting an estimated $4.17M.
  • Washington Trust Advisors fully exited Ametek in Q3 2024, selling an estimated $38.9K.
  • Washington Trust Advisors's ten largest holdings make up 38% of its $1.16B portfolio in Q3 2024.
  • Washington Trust Advisors opened 30 new positions and closed 27 in Q3 2024.
  • Washington Trust Advisors's portfolio value rose 6.7% quarter-over-quarter to $1.16B.

Based on Washington Trust Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.